New Results from Examining Anti-Cancer Effects of Immune-12 on GBM Cells
Andrew Satterlee from UNC presented Immune 12 pre-clinical research at the 7th Quadrennial Meeting of the World Federation of Neuro-Oncology Societies, held in conjunction with the 30th Society for Neuro-Oncology (SNO) Annual Meeting & Education Day in Honolulu, Hawaii. Nov. 19-23, 2025.